Want to see IN:BHARATRAS full AI Analyst Report?
Bharat Rasayan Limited (BHARATRAS) AI Stock Analysis
Bharat Rasayan Limited
(NSE:BHARATRAS)
The overall score is driven primarily by strong financial performance, with rising revenues and profits, double‑digit margins, and an exceptionally low‑debt balance sheet that supports resilience through industry cycles. Attractive valuation, featuring a low earnings multiple and a reasonable dividend yield, further underpins the stock’s appeal. These strengths are partially offset by weaker technicals—price below key moving averages, negative momentum indicators, and elevated volatility—and by the historical volatility in cash flows and recent margin and cash‑generation softness, which temper the score below the highest tier.
Bharat Rasayan Limited (BHARATRAS) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 15.57B
- Dividend Yield
- 0.05%
- Average Volume (3M)
- 1,806
- Price to Earnings (P/E)
- 6.9
- Beta (1Y)
- 1.52
- Revenue Growth
- -5.17%
- EPS Growth
- 4.24%
- Country
- India
- Employees
- 903
- Sector
- General
- Sector Strength
- 55
- Industry
- Agricultural Inputs
Bharat Rasayan Limited Business Overview & Revenue Model
Company Description
Established in 1989 and headquartered in New Delhi, India, Bharat Rasayan Limited is a key producer and distributor of agrochemical products. The company specializes in technical grade pesticides, encompassing insecticides, herbicides, and fungicides...
How the Company Makes Money
Bharat Rasayan Limited primarily makes money by manufacturing and selling agrochemical products across the crop protection value chain. Its core revenue stream is the sale of technical-grade active ingredients (i.e., concentrated, technical material...
Bharat Rasayan Limited Financial Statement Overview
Summary
Financial performance is strong overall, with revenue and net profit rising in FY 2025 and FY 2026, attractive double‑digit profit margins, and an exceptionally low‑leverage balance sheet. However, gross and operating margin compression versus prior peak years and volatile operating and free cash flow, including a negative outturn in FY 2022 and a notable decline in FY 2026, prevent a top‑tier score.
Income Statement
78PositiveBalance Sheet
88Very PositiveCash Flow
70Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.03B | 12.42B | 11.73B | 10.45B | 12.34B | 12.95B |
| Gross Profit | 3.01B | 3.19B | 3.96B | 3.24B | 3.95B | 3.69B |
| EBITDA | 1.95B | 2.24B | 2.01B | 1.38B | 2.06B | 2.66B |
| Net Income | 1.43B | 1.46B | 1.41B | 955.10M | 1.25B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 0 | 14.33B | 14.08B | 11.97B | 10.74B | 10.86B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.73B | 2.86B | 1.41B | 485.96M | 66.88M |
| Total Debt | 0 | 12.26M | 852.19M | 804.74M | 279.37M | 1.74B |
| Total Liabilities | -12.75B | 1.58B | 2.78B | 2.10B | 1.80B | 3.16B |
| Stockholders Equity | 12.75B | 12.75B | 11.30B | 9.88B | 8.93B | 7.70B |
Cash Flow | ||||||
| Free Cash Flow | -161.72M | 545.22M | 1.32B | 140.26M | 1.90B | -1.21B |
| Operating Cash Flow | 249.00K | 1.28B | 1.68B | 410.76M | 2.13B | -654.55M |
| Investing Cash Flow | -173.93M | -963.94M | -1.57B | -897.00M | -605.49M | 511.36M |
| Financing Cash Flow | 23.25M | -846.16M | 41.22M | 489.57M | -1.52B | -247.85M |
Bharat Rasayan Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Negative. The current price of 950.20 is below the 20-day moving average (MA) of 971.36, below the 50-day MA of 1095.26, and below the 200-day MA of 1384.12, indicating a bearish trend. The MACD of -43.58 indicates Negative momentum. The RSI at 27.78 is Positive, neither overbought nor oversold. The STOCH value of 12.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BHARATRAS.
Bharat Rasayan Limited Peers Comparison
Overall Rating
IN:BHARATRAS74Outperform
IN:DHANUKA73Outperform
IN:IPL66Neutral
IN:RALLIS63Neutral
IN:INSECTICID58Neutral
IN:PIIND56Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | INR 15.49B | 6.86 | ― | 0.05% | -5.17% | 4.24% | |
| 73Outperform | INR 43.75B | 16.48 | ― | 0.20% | -5.63% | -11.38% | |
| 66Neutral | INR 12.97B | 12.05 | ― | 0.67% | 17.05% | 9.10% | |
| 63Neutral | INR 35.75B | 18.14 | ― | 1.63% | 6.82% | 11.93% | |
| 58Neutral | INR 15.10B | 11.82 | ― | 0.39% | 1.26% | -16.43% | |
| 56Neutral | INR 316.94B | 27.34 | ― | 0.48% | -16.57% | -27.71% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:BHARATRAS | Bharat Rasayan Limited | 931.80 | -1752.46 | -65.29% | |
| IN:DHANUKA | Dhanuka Agritech Limited | 981.50 | -322.04 | -24.70% | |
| IN:INSECTICID | Insecticides (India) Limited | 519.10 | -200.11 | -27.82% | |
| IN:IPL | India Pesticides Ltd. | 112.60 | -77.23 | -40.68% | |
| IN:PIIND | PI Industries Limited | 2089.00 | -1580.52 | -43.07% | |
| IN:RALLIS | Rallis India Limited | 183.85 | -75.13 | -29.01% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 28, 2026